PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcvetresBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Veterinary Research
 
BMC Vet Res. 2012; 8: 36.
Published online Mar 28, 2012. doi:  10.1186/1746-6148-8-36
PMCID: PMC3348074
A novel bead-based assay to detect specific antibody responses against Toxoplasma gondii and Trichinella spiralis simultaneously in sera of experimentally infected swine
Gertie CAM Bokken,corresponding author1 Aldert A Bergwerff,1,2 and Frans van Knapen1
1Institute for Risk Assessment Sciences (IRAS), Division of Veterinary Public Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 2, 3584 CM Utrecht, The Netherlands
2Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
corresponding authorCorresponding author.
Gertie CAM Bokken: G.C.A.M.Bokken/at/uu.nl; Aldert A Bergwerff: a.bergwerff/at/rnassays.com; Frans van Knapen: F.vanKnapen/at/uu.nl
Received October 28, 2011; Accepted March 28, 2012.
Background
A novel, bead-based flow cytometric assay was developed for simultaneous determination of antibody responses against Toxoplasma gondii and Trichinella spiralis in pig serum. This high throughput screening assay could be an alternative for well known indirect tests like ELISA. One of the advantages of a bead-based assay over ELISA is the possibility to determine multiple specific antibody responses per single sample run facilitated by a series of antigens coupled to identifiable bead-levels. Furthermore, inclusion of a non-coupled bead-level in the same run facilitates the determination of, and correction for non-specific binding. The performance of this bead-based assay was compared to one T. spiralis and three T. gondii ELISAs. For this purpose, sera from T. gondii and T. spiralis experimentally infected pigs were used. With the experimental infection status as gold standard, the area under the curve, Youden Index, sensitivity and specificity were determined through receiver operator curve analysis. Marginal homogeneity and inter-rater agreement between bead-based assay and ELISAs were evaluated using McNemar's Test and Cohen's kappa, respectively.
Results
Results indicated that the areas under the curve of the bead-based assay were 0.911 and 0.885 for T. gondii and T. spiralis, respectively, while that of the T. gondii ELISAs ranged between 0.837 and 0.930 and the T. spiralis ELISA was 0.879. Bead-based T. gondii assay had a sensitivity of 86% and specificity of 96%, while the ELISAs ranged between 64-84% and 93-99%, respectively. The bead-based T. spiralis assay had a sensitivity of 68% and specificity of 100% while the ELISA scored 72% and 95%, respectively. Marginal homogeneity was found between the T. gondii bead-based test and one of the T. gondii ELISAs. Moreover, in this test combination and between T. spiralis bead-based assay and respective ELISA, an excellent inter-rater agreement was found. When results of samples before expected seroconversion were removed from evaluation, notably higher test specifications were found.
Conclusions
This new bead-based test, which detects T. gondii and T. spiralis antibodies simultaneously within each sample, can replace two indirect tests for the determination of respective antibodies separately, while performing equally well or better.
Trichinella spiralis and Toxoplasma gondii are well known zoonoses which can pass from pigs to humans by consumption of raw or undercooked infected pork. In humans, most cases of T. gondii and T. spiralis infections go undetected; however, some cases can lead to mild disease. Other cases of trichinellosis can be very severe and may lead to myocarditis, encephalitis or pneumonia. Post natal acquired toxoplasmosis can incidentally lead to encephalitis and necrotizing retinochoroiditis, while congenital transmitted toxoplasmosis can lead to mental retardation, convulsions, spasticity, cerebral palsy, deafness and severely impaired vision in the offspring. In rare occasions, both these infections can lead to death.
These days, in Europe, trichinellosis is rarely reported in association with the consumption of pork from conventionally raised pigs [1]. An EU regulation [2] directs inspection of T. spiralis in each pig carcass at slaughter by direct parasitological methods. This regulation also states that serological tests may be implemented as a supplement for monitoring purposes.
Unlike T. spiralis, no such regulations exist for T. gondii, although the prevalence of this parasite in pigs is higher and health consequences of toxoplasmosis can be, like those of trichinellosis, rather serious. For example, in a Dutch survey in 2004, T. gondii infection was found in 2.6% of the studied pigs [3], while in that year none of the over 13 million slaughtered pigs were found T. spiralis positive [4].
Consumption of raw or undercooked T. gondii infected pork may cause toxoplasmosis in humans. Obviously, determination of the T. gondii status of the meat producing pigs, subsequently followed by precautionary methods, like freezing of pork to kill the parasite or altogether removal of this meat from the food chain, could contribute to fewer infections in humans. A Dutch study which assessed the epidemiology and impact of, amongst others, T. gondii infections in humans indicated that this parasite is one of the major contributors of disease through zoonotic transmission [5]. Similarly, an American study indicated that T. gondii in pork ranked second on the list of the zoonotic micro-organisms with the greatest impact on annual disease burden in that country [6] and was only surpassed by Campylobacter in chicken. In a scientifically opinion to the European Food Safety Authority (EFSA) it is recommended that standardized methods should be used on T. gondii pre-harvest monitoring of, amongst others, pigs [7].
Like T. spiralis, the T. gondii infection status of animals can be examined by serological tests in order to produce T. gondii controlled pork. Testing serum samples of finisher pigs requires an automated and easy to perform test method with a high sensitivity (Se) and specificity (Sp). Enzyme-linked immunosorbent assays (ELISAs) are such test methods which are commonly used.
Bead-based assays (BBA) are a new dimension in the determination of specific antibody responses. The test is performed on beads which are available in different sizes and levels. During flow cytometric analysis individual beads are distinguishable by size and intrinsic fluorescence intensity level. The bead surface is carboxylate modified, which allows covalent coupling of protein. The great advantage of these tests over ELISA is the possibility of simultaneous detection of specific responses against multiple antigens per single serum sample. More specifically, by individual coupling of antigens to specific bead levels, and combination of these bead levels per test sample, a multitude of specific responses can be determined simultaneously per sample. Furthermore, by the use of a non-coupled bead, non-specific binding (NSB) can be monitored and corrected for. The use of T. gondii and T. spiralis antigens on two bead levels in a combined bead-based test to determine the serological status of swine would provide a new innovative assay which could be used as an alternative to ELISA in a T. gondii and T. spiralis monitoring system.
In this report, the specifications of a bead-based array test, with combined T. gondii and T. spiralis antigen bead levels to determine specific antibodies in serum of experimentally infected swine, are evaluated and compared to commercial and non-commercial ELISAs.
Porcine sera
Experimental infection sera
Swine serum samples originated from an experimental co-infection of pigs with T. gondii and T. spiralis [8]. Before infection, animals used in the experiment were assumed T. gondii and T. spiralis free on basis of the post partum determined negative serological status of sows which gave birth to these animals [8]. Briefly, eight to nine week old animals had been singly (T. gondii n = 8, T. spiralis n = 10), simultaneously (n = 10), or successively (T. gondii/T. spiralis n = 9, T. spiralis/T. gondii n = 10) orally inoculated with either 2,700 or 2,000 T. gondii tissue cysts (strain DX) and/or 5,000 T. spiralis muscle larvae (strain ISS 14) per pig. Because two animals of the T. spiralis/T. gondii inoculated group did not seem to be infected, they were excluded from the experiment [8]. A total of 444 serum samples were collected in series at 0, 5, 12, 19, 26, 33, 40, 47 and 54 days post infection (p.i.) from 45 pigs and four additional non-inoculated animals which served as negative control animals. This animal study, under number DEC 2008.III.03.023, was reviewed and approved by the local animal ethics committee according to the recommendations of the EU directive 86/609/EEC. Numbers of animals and their suffering were minimized.
Negative field sera
Blood samples of conventional finisher pigs were collected for Salmonella baseline monitoring at the abattoir in 2007 by the Dutch Food and Consumer Product Safety Authority (nVWA). The blood was left at room temperature with a minimum of 2 hours to clot and subsequently centrifuged for 10 minutes at 1,100 × g. Serum was drawn and dispensed in aliquots and kept at -20°C until further use.
Serum samples were analyzed by a commercially obtained T. gondii ELISA (ID Screen Toxoplasmosis Indirect, ID-VET, Montpellier, France; hereafter referred as E3-TOX). Serum samples remaining under the designated cut-off value of the ELISA were considered to originate from T. gondii infection negative pigs. Because during the sample period no pigs with T. spiralis infections were reported [9], all animals were considered T. spiralis infection negative.
Indirect assays
Sera from the experimentally infected animals were tested by the bead-based assay for T. gondii and T. spiralis antibodies simultaneously (hereafter referred to as BBA-TOX and BBA-TRI, respectively), by an RIVM in-house T. gondii ELISA (hereafter referred to as E1-TOX) and two commercially available T. gondii ELISA kits (Safepath, Carlsbath, CA, USA, hereafter referred to as E2-TOX) and E3-TOX, and by one T. spiralis ELISA (Safepath, hereafter referred to as E-TRI). All T. gondii indirect tests used an antigen based on T. gondii tachyzoites, of which E3-TOX utilized a recombinant tachyzoite surface protein (SAG-1) as antigen. The T. spiralis tests were based on ES antigens. Bead-based assays were run according to the specifications described in the section bead-based assay. Testing with the in-house ELISA [3] was described earlier [8] and included an intra-plate correction of E1-TOX data. All commercial ELISAs were run according to the specification of the kit providers. For E3-TOX, normalization of data was included.
Bead-based assay
A bead-based assay was developed for simultaneous detection of specific antibodies which were captured by T. spiralis and T. gondii antigens on two different bead levels. NSB was recorded with reference beads, which is a bead level without coupled antigens. Each bead level was recognized via the emission of light with a unique intensity and wavelength of the beads intrinsic fluorescence. Specific and NSB in each individual serum sample were determined by the extrinsic response, which was generated by the emission of light by a fluorophore attached to the secondary antibody. Because NSB may vary between serum samples, the extrinsic response of reference beads was used to determine the non-specific response. To obtain a specific response per individual serum sample, this non-specific response was subtracted from the response of coupled beads. A BD Accuri flow cytometer was used for enumeration of micro-particles, excitation of fluorescent markers and measurement of emitted light from these markers.
Chemicals, materials and solutions
L4, L10 and L11 carboxylated Cyto-plex™ beads (cat# FM5CR04, FM5CR10 and FM5CR11, respectively) were purchased from Thermo Scientific (Waltham, MA, USA). T. gondii tachyzoite lysate, strain RH (cat#: R29123) was from Meridian Life Science Inc. (Saco, ME, USA). T. spiralis Excretory/Secretory antigen (ES) was obtained from Instituto Superiore Sanità (Rome, Italy). Microcentrifuge copolymer tubes (cat# 1415-2500) were acquired from Star Lab GmbH (Ahrensberg, Germany). N-hydroxysulfosuccinimide sodium salt (sNHS), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC; cat#: 03449) and 2-(N-morpholino)ethanesulfonic acid hydrate (MES; cat#: M8250) were bought from Sigma-Aldrich Chemie B.V. (Zwijndrecht, the Netherlands). A 45 mM MES buffer was prepared and adjusted to pH 6.0 with sodium hydroxide. PBS at pH 7.2 consisted of 0.01 M sodium chloride (NaCl, Merck KGaA, Darmstadt, Germany), 1 mM di-sodium hydrogen phosphate (Merck) and 3 mM potassium dihydrogen phosphate (Merck). Water was of milliQ quality. Storage buffer and HNT-PBS solution were provided by RnAssays (Utrecht, the Netherlands). The 0.45 μm filter plates (cat#: MSHVN4550) were from Millipore (Amsterdam, the Netherlands). Goat anti-swine secondary antibody conjugated with fluorescent DyLight 488 was purchased from Jackson Immuno Research (West Grove, PA, USA).
Bead coupling procedure
T. gondii tachyzoite lysate and T. spiralis Excretory/Secretory antigen (ES) were coupled to carboxylated beads through an amine coupling procedure. Briefly, an equivalent of 1.4 × 108 carboxylated beads of L10 and L11 were transferred to two 1.5 ml copolymer tubes. The beads were washed by three repeats of following steps: a 3 minutes centrifugation at 9,000 ×g, removal of the supernatant, addition of 1 ml water per tube and resuspension of the beads on a vortex. After the third removal of supernatant, beads from both tubes were resuspended in 1.1 ml solution consisting of 12.5 mg sNHS and 12.5 mg EDC in MES buffer. This suspension was incubated for 20 minutes at room temperature on a gyro rocker at 70 rpm. Beads were washed 2 more times with 500 μl water as described above and after removal of the supernatant, 50 μg of T. gondii lysate and 10 μg T. spiralis ES dissolved in 200 μl PBS pH 7.4 were added to the activated L10 and L11 beads, respectively. Resuspended beads were left to incubate for 2 hours on a gyro rocker at 70 rpm, washed and stored in a storage buffer. A non-coupled L4 reference bead suspension was produced with the same protocol with exception of the protein incubation step which was substituted by PBS incubation. This L4 bead is referred to as the reference bead.
Assay procedure
Two 0.45 μm filter plates were soaked with 150 μl of a 0.2 μm filtered solution of HNT-PBS, subsequently incubated for five minutes at ambient temperature, and emptied by vacuum filtration. Serum samples were diluted 1:50 in HNT-PBS, transferred to a soaked and aspirated 0.45 μm filter plate, filtered with the use of the vacuum manifold and collected in an empty 96-wells plate. Thereafter, in another soaked filter plate, a quantity of approximately 5 × 105 T. gondii and T. spiralis antigen coupled beads and reference beads were suspended in 50 μl of HNT-PBS per well. Subsequently, one equivalent volume of filtered diluted sera was mixed and incubated with the bead-mix per well for 15 minutes on an orbital shaker (1,050 rpm). Beads were washed with 200 μl HNT-PBS by aspiration and additionally incubated with 100 μl 1:300 in HNT-PBS diluted fluorescent secondary antibody for 15 minutes. Finally, beads were washed once more and suspended in 100 μl HNT-PBS. Due to light sensitivity of beads and fluorescent reporter the filter plates were protected from light during incubation steps.
Internal and external fluorescent detection
A total of 600 beads per serum sample were analyzed for the intrinsic bead label on the FL4 channel, and extrinsic fluorescence reporter label on the FL1 channel using a BD Accuri C6 flow cytometer (BD Accuri Cytometers, Inc. Ann Arbor, MI, USA). The detector was equipped with a CSampler liquid handler (BD Accuri) and operated through CFlow software (version 1.0.243.1, BD Accuri). Beads were transported at a flow rate of 35 μl/min. The emission of the intrinsic fluorescence of the three bead levels, measured by the FL4 filter at 675 nm, was used to distinguish the T. gondii (TOX), T. spiralis (TRI) and reference (REF) beads. The median extrinsic fluorescence intensity (MFI) of the secondary antibody per bead level was determined by measuring the emission via the FL1 filter at 530 nm.
Correction for non-specific binding
Reference beads were used to indicate the measure of NSB in the test. Differences in NSB on uncoupled or antigen coupled bead levels may be expected due to differences in affinity of beads for non-specific antibodies caused by the molecular structure of the antigen, its orientation and concentration on the bead surface. Therefore, to estimate the NSB on T. gondii and T. spiralis bead levels from the response of a reference bead, a correction factor was calculated by testing 932 T. gondii and 13 extra T. spiralis negative swine sera (section Negative field sera) in the bead-based assay. With the use of least square regression, linear relations, expressed with the formulae y = slope*x + intercept, the relation between responses of the reference beads (x value) and T. gondii and T. spiralis bead responses (y values) were calculated in SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA). Because the residuals of the linear relation between responses of T. gondii and T. spiralis bead levels and reference bead responses were not normally distributed, all responses were log transformed.
Normalization of responses
To compare results between 96-wells plates, serum samples responses were normalized. The percentage of normalized responses (%NR) was calculated as a percentage of sample responses (MFIS) of a positive control response (MFIPC), which was present in quadruplicate on each plate, after subtraction of NSB (sections Correction for non-specific binding and Results and Discussion).
equation M1
(1)
where subscript T represents T. gondii or T. spiralis in the considered case.
Statistical analysis
All statistical evaluations were performed with SPSS.
To specify the performance of the bead-based assay, expressed in area under the curve (AUC), receiving operator characteristic (ROC) calculations were performed using the experimental infection status as gold standard. Analysis was performed on the %NR of the BBA and E3-TOX, and OD450nmof the other ELISAs. ROC calculations were also performed on limited sets of serum from the experimental infection. These sets consisted of all samples minus serum samples drawn 5 days after inoculation with T. gondii (n = 408) and all samples minus serum samples drawn 5, 12 and 19 days after inoculation with T. spiralis (n = 360), for the T. gondii and T. spiralis indirect tests, respectively. To further specify the tests, diagnostic Sensitivity (Se), Specificity (Sp) and cut-off values at maximum Youden Index were determined from ROC calculations [10].
To assess the agreement between tests, the marginal homogeneity of paired proportions [11] were tested by McNemar's in a 2 × 2 contingency table. Furthermore, inter-rater agreement was calculated using Cohen's Kappa. For this, serum responses of all tests were labelled 0 (negative), when they were below the cut-off value or 1 (positive) when they were equal or above cut-off value. These dichotomized outcomes where then evaluated against the dichotomized outcomes of the other tests. Kappa values between 0.40 - 0.59, 0.60 - 0.79 and ≥ 0.80 are interpreted as moderate, substantial and excellent agreement, respectively [11].
The apparent prevalence (AP) is the proportion of the population which tests positive in the test, which is a measure of true prevalence (TP) and the capability of the test to predict true positives and negatives, and it was calculated as [12]:
equation M2
(2)
where TP is the proportion of actual infected animals which was calculated by:
equation M3
(3)
where n is the number of sera which originate from inoculated animals, and N is the total number of sera.
Results from T. gondii and T. spiralis negative field samples, negative control serum of the experimental infection and secondary antibody binding alone (Table (Table1)1) showed that the height of NSB responses is foremost dependent of the presence of serum. Observing that negative sera due to NSB can reach the same or higher responses as for example positive control serum of 250,000 MFI on T. gondii and 500,000 MFI on T. spiralis beads (data not presented), it is concluded that correction for NSB is necessary to prevent false positive results.
Table 1
Table 1
Non specific binding responses of T.gondii and T. spiralis negative serum sets and conjugate alone
The results of T. gondii and T. spiralis negative field sera illustrate that the response of the reference beads could not directly be used as a measure for non-specific binding. The log linear relations between responses of reference beads and T. gondii or T. spiralis beads are depicted in Figures Figures11 and and2,2, and the relations were expressed as:
Figure 1
Figure 1
Estimation of T. gondii non-specific binding correction factor. Log transformed responses of T. gondii negative swine field sera on non-coupled beads (x-axis) versus T. gondii coupled beads (y-axis). Linear regression line (log y = 0.404* log x + 2.818), (more ...)
Figure 2
Figure 2
Estimation of T. spiralis non-specific binding correction factor. Log transformed responses of T. spiralis negative swine field sera on non-coupled beads (x-axis) versus T. spiralis coupled beads (y-axis). Linear regression line (log y = 0.646*log x + (more ...)
equation M4
(4)
equation M5
(5)
The slopes of the two regression lines indicate that T. gondii beads are subject to less NSB as compared to T. spiralis beads. This finding may be explained by, for example, variable concentration of antigens on the bead, differences in antigen molecule structures and orientation on the bead surface and/or the affinity between non-specific antibodies and the unoccupied bead surface or coupled antigens. A variety in antigen composition between biologically produced batches can therefore be of importance in relation to NSB. To test whether the correction factor to calculate bead correlated NSB is stable between batches of antigen, further evaluation is necessary. Subtraction of uncorrected responses of reference beads, according to formula 1, would lead to an underestimation or overestimation of NSB for responses below and above 53,480 and 183,110 for T. gondii and T. spiralis, respectively.
Results of ROC calculations, presented in Table Table2,2, showed that the AUC, a measure of agreement between specific responses and the experimental infection status of the animals, of all indirect tests ranged between 0.837 and 0.930 for T. gondii and 0.855 and 0.879 for T. spiralis. These values indicate that there is a good relation between the responses of all indirect tests and the infection status of the animals.
Table 2
Table 2
Infection status based specifications of bead-based assay and ELISA tests calculated by ROC analysis
A perfect test is a test in which the responses correspond 100%, i.e. an AUC of 1.000, with the values of the test to which it is compared. The imperfect AUC values (< 1.000) found in our study (Table (Table3)3) can partly be explained by a late immunological development of antibodies, which is associated to the time course of parasite antigen expression and the immune response of infected animals. Evidence from earlier studies showed that muscle larvae, depending on the infection dose, can be found in pork by digestion or trichinoscopy as early as 17 days p.i. [13]. Other studies showed that T. spiralis ES could be measured within the developing muscle larvae and its cuticular surface as early as 14 days p.i. [14] and in the surrounding tissue around 15 days p.i. [15]. Consequently, the response time, i.e. the time of development of antibodies against the antigen used in the indirect T. spiralis assays, is affected by this late production. Porcine IgG antibodies against ES are developed approximately 3 to 4 weeks after infection with 5,000 muscle larvae [16,17]. Porcine IgG antibodies against T. gondii tachyzoites are produced much earlier in time and can be detectable after one to two weeks of infection [18]. In our study, the sera used for ROC calculations originated from animals which were collected on a weekly basis [8]. Samples drawn 5 days after T. gondii inoculation and 5, 12 and 19 days after T. spiralis inoculation would produce a false negative result when compared to the experimental infection status, resulting in lower AUC values. Calculations of ROC curves without these sera resulted in notably higher AUC values of 0.995, 0.999, 0.998 and 0.999 for BBA-TOX, E3-TOX, BBA-TRI and E-TRI, respectively (Figures (Figures33 and and44).
Table 3
Table 3
Inter-test agreement between assays calculated by McNemar's and Cohen's Kappa analysis
Figure 3
Figure 3
ROC curves of T. gondii assays calculated with a limited serum set from experimental infection. ROC analysis of a T. gondii bead-based assay and three ELISAs using responses from a set of serum samples, consisting of sera from experimentally infected (more ...)
Figure 4
Figure 4
ROC curves of T. spiralis assays calculated with a limited serum set from experimental infection. ROC analysis of a T. spiralis bead-based assay and ELISA using responses from a set of serum samples, consisting of sera from experimentally infected pigs (more ...)
According to data of test performances and inter test agreement, presented in Table Table3,3, the T. gondii and T. spiralis bead assays agree excellently with their respective highest scoring tests, i.e. with the E-TOX3 and E-TRI, respectively. Marginal homogeneity by McNemars test, a test which determines the equality between positive and negative test proportions of one test compared to the other, indicated that there is a balance between BBA-TOX and E-TOX3.
The potential use of the bead based test is prevention of T. gondii and/or T. spiralis infections in pork to enter the human food chain. Nonetheless, direct parasitological testing, like T. spiralis artificial digestion, are more reliable methods to test for present infection in meat. Existing T. gondii direct tests are either laborious, e.g. due to the need of pathogen extraction in PCR [19], or are undesirable because of utilization of experimental animals, like in cat and mice bioassays [20], to determine the infectious status of meat. In the case of T. gondii infections, serological testing is the next best option to perform on large scale. Unfortunately, due to the time window between infection and development of specific antibody responses, serological tests are less reliable for detection on individual scale; however, they can be used for monitoring purposes on herd level [21].
To prevent human T. gondii and T. spiralis infections through consumption of infected pork by serological monitoring of pig herds, a high sensitivity of 99% [22], and an approximation of AP to TP (Table (Table4)4) is desired. None of the assays used for this paper met this requirement. However, when ROC calculations were restricted to serum samples in which antibody responses were to be expected, as was described above, the sensitivity was 97% and 99% for BBA-TOX and BBA-TRI, respectively (data not presented). Subsequent calculations for true and apparent prevalence resulted in an overall T. gondii TP of 52.7% and AP's of 51.5% and 53.3% for BBA and ELISA, respectively. The overall TP of T. spiralis was 44.4% while the APs were 44.1% and 44.3% for BBA and ELISA, respectively (data not presented). These data would indicate that the combined bead-based assay is applicable for serological monitoring purposes.
Table 4
Table 4
Comparison of true and apparent prevalence's of pig sera between indirect assays
Although we compared our new T. gondii and T. spiralis bead test with a limited selection of available ELISAs, the test specifications and agreement between tests examined in this study indicate that the combined bead test equals or is superior to other tests. However, all calculations have been based upon tests using serum samples of experimentally infected pigs, which were exposed to high doses of parasites. Conventionally raised animals are likely to be infected by lower doses of parasites, and sero-conversion may be detected later in time [16-18]. Therefore, to determine the applicability of this bead-based test for the use of indirect detection of infection, it is advisable to further evaluate the test by the use of serum samples of naturally infected pigs.
Conclusions
In conclusion, this initial evaluation study of a novel bead-based assay capable of a simultaneous detection of serological antibodies against T. gondii and T. spiralis antigens indicates that the test results correspond very well to the infection status of the animals, and, furthermore, there is a substantial to excellent agreement with other indirect tests. In order to estimate the applicability of this test for purposes of serological monitoring, further testing of sera from naturally infected animals is required.
Authors' contributions
GCAMB helped in conceiving of the study, developed and optimized the bead-based test method, analyzed serological material in the test methods, statistically interpreted the data and wrote the manuscript. AAB and FvK both conceived of the study, participated in its design and coordination, contributed their expertise and helped to draft the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was partly supported through material gifts and a financial grant from RNassays, Utrecht, The Netherlands. The authors would like to thank Marieke Opsteegh of the RIVM for her analysis of serum samples by the in-house T. gondii ELISA. Furthermore, we are grateful for the help of Sevda Atanasova and Wouter Harink of RnAssays in optimization of the bead assay and flow cytometric analysis. Lastly, we would like to thank Giuseppe Cacciatore for his input of expertise in assay processes and statistical calculations.
  • Anonymous. European Food Safety Authority. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009. EFSA Journal. 2011;9(3):2090. http://www.efsa.europa.eu/en/efsajournal/pub/2090.htm
  • European Union. Commission Regulation 2075/2005 of 5 December 2005 Laying Down Specific Rules on Official Controls for Trichinella in Meat
  • Giessen Jvd, Fonville M, Bouwknegt M, Langelaar M, Vollema A. Seroprevalence of Trichinella spiralis and Toxoplasma gondii in pigs from different housing systems in The Netherlands. Vet Parasitol. 2007;148(3/4):371–374. [PubMed]
  • Anonymous. The Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial resistance in the European Union in 2004. EFSA Journal. 2005;3(12):310. http://www.efsa.europa.eu/de/efsajournal/pub/310ar.htm
  • Havelaar AH, van Rosse F, Bucura C, Toetenel MA, Haagsma JA, Kurowicka D, Heesterbeek APJ, Speybroeck N, Langelaar MFM, van der Giessen JWB, Cooke RM, Braks MAH. Prioritizing emerging zoonoses in the Netherlands. PLoS ONE. 2010;5(11) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0013965
  • Batz MB, Hoffmann S, Morris JG. , JrRanking the Risks: The 10 Pathogen-Food Combinations With The Greatest Burden on Public Health. http://www.rwjf.org/files/research/72267report.pdf
  • Andreoletti O, Budka H, Buncic S, Colin P, Collins JD, De Koeijer A, Griffin J, Havelaar A, Hope J, Klein G, Kruse H, Magnino S, Martinez López A, McLauchlin J, Nguyen-Thé C, Noeckler K, Noerrung B, Prieto Maradona M, Roberts T, Vågsholm I, Vanopdenbosch E. Surveillance and monitoring of Toxoplasma in humans, food and animals - Scientific Opinion of the Panel on Biological Hazards. EFSA Journal. 2007;5(12):583. http://www.efsa.europa.eu/en/efsajournal/doc/583.pdf
  • Bokken GCAM, van Eerden E, Opsteegh M, Augustijn M, Graat EAM, Franssen FFJ, Görlich K, Buschtöns S, Tenter AM, van der Giessen JWB, Bergwerff AA, van Knapen F. Specific serum antibody responses following a Toxoplasma gondii and Trichinella spiralis co-infection in swine. Vet Parasitol. 2012;184(2-4):126–132. doi: 10.1016/j.vetpar.2011.08.028. [PubMed] [Cross Ref]
  • Anonymous. The Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial resistance in the European Union in 2007. EFSA Journal. 2009;7(1):223. http://www.efsa.europa.eu/en/efsajournal/pub/223r.htm
  • Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000;45(1-2):23–41. doi: 10.1016/S0167-5877(00)00115-X. [PubMed] [Cross Ref]
  • Landis JR, Koch GG. The Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33(1):159–174. doi: 10.2307/2529310. [PubMed] [Cross Ref]
  • Henken AM, Graat EAM, Casal J. In: Application of Quantitative Methods in Veterinary Epidemiology. Noordhuizen JPTM, Frankena K, Thrusfield MV, Graat EAM, editor. Wageningen: Wageningen Pers; 2001. Measurement of disease frequency; pp. 63–96.
  • van Knapen F, Franchimont JH, Ruitenberg EJ, André P, Baldelli B, Gibson TE, Gottal C, Henriksen SA, Kohler G, Ronéus O, Skovgaard N, Soulé C, Strickland KL, Taylor SM. Comparison of four methods for early detection of experimental Trichinella spiralis infections in pigs. Vet Parasitol. 1981;9(2):117–123. doi: 10.1016/0304-4017(81)90030-3. [PubMed] [Cross Ref]
  • Despommier DD, Gold AM, Buck SW, Capo V, Silberstein D. Trichinella spiralis: Secreted antigen of the infective L1 larva localizes to the cytoplasm and nucleoplasm of infected host cells. Exp Parasitol. 1990;71(1):27–38. doi: 10.1016/0014-4894(90)90005-W. [PubMed] [Cross Ref]
  • Li CK, Chung YY, Ko RC. The distribution of excretory/secretory antigens during the muscle phase of Trichinella spiralis and T. pseudospiralis infections. Parasitol Res. 1999;85(12):993–998. doi: 10.1007/s004360050671. [PubMed] [Cross Ref]
  • van der Leek ML, Dame JB, Adams CL, Gillis KD, Littell RC. Evaluation of an enzyme-linked immunosorbent assay for diagnosis of trichinellosis in swine. Am J Vet Res. 1992;53(6):877–882. [PubMed]
  • Gottstein B, Pozio E, Nockler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. 2009;22(1):127–145. doi: 10.1128/CMR.00026-08. [PMC free article] [PubMed] [Cross Ref]
  • Lind P, Haugegaard J, Wingstrand A, Henriksen SA. The time course of the specific antibody response by various ELISAs in pigs experimentally infected with Toxoplasma gondii. Vet Parasitol. 1997;71(1):1–15. doi: 10.1016/S0304-4017(97)00010-1. [PubMed] [Cross Ref]
  • Opsteegh M, Langelaar M, Sprong H, Hartog Ld, Craeye Sd, Bokken G, Ajzenberg D, Kijlstra A, Giessen J. Direct detection and genotyping of Toxoplasma gondii in meat samples using magnetic capture and PCR. Int J Food Microbiol. 2010;139(3):193–201. doi: 10.1016/j.ijfoodmicro.2010.02.027. [PubMed] [Cross Ref]
  • Dubey JP, Hill DE, Jones JL, Hightower AW, Kirkland E, Roberts JM, Marcet PL, Lehmann T, Vianna MCB, Miska K, Sreekumar C, Kwok OCH, Shen SK, Gamble HR. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: Risk assessment to consumers. J Parasitol. 2005;91(5):1082–1093. doi: 10.1645/GE-683.1. [PubMed] [Cross Ref]
  • Ruitenberg EJ, van Knapen F, Elgersma A. In: Trichinella and Trichinosis. 1. Campbell WC, editor. New York: Plenum Press; 1983. Surveillance in swine by immunodiagnostic methods; pp. 529–550.
  • van Knapen F. Control of trichinellosis by inspection and farm management practices. Vet Parasitol. 2000;93(3-4):385–392. doi: 10.1016/S0304-4017(00)00353-8. [PubMed] [Cross Ref]
Articles from BMC Veterinary Research are provided here courtesy of
BioMed Central